Filing Details
- Accession Number:
- 0001556247-12-000003
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2012-11-09 10:27:37
- Reporting Period:
- 2012-11-08
- Filing Date:
- 2012-11-09
- Accepted Time:
- 2012-11-09 10:27:37
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
872589 | Regeneron Pharmaceuticals Inc | REGN | Pharmaceutical Preparations (2834) | 133444607 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1377247 | Peter Powchik | 777 Old Saw Mill River Road Tarrytown NY 10591 | Svp Clinical Development & Reg | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2012-11-08 | 14,244 | $138.59 | 15,890 | No | 4 | S | Direct | |
Common Stock | Disposition | 2012-11-08 | 900 | $139.05 | 14,990 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 1,532 | Indirect | By 401(k) Plan |
Footnotes
- Represents volume-weighted average price of sales of 14,244 shares of Company stock on November 8, 2012 at prices ranging from $138.47 to $138.98. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2012 at each separate price.
- Represents volume-weighted average price of sales of 900 shares of Company stock on November 8, 2012 at prices ranging from $139.00 to $139.27. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on November 8, 2012 at each separate price.